The use of key immunohistochemical markers, such as S100, SOX10, Melan-A (MART1), HMB-45, and MITF, have demonstrated varying degrees of sensitivity and specificity for the diagnosis of melanoma, assessment of prognostic factors, and guiding of therapeutic decisions [11,12]. The gene discussed is MLANA; the disease is melanoma.